Article
E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells.
Instituto de Patologia e Immunologia Molecular da Universidade do Porto, Portugal.
Human Molecular Genetics (impact factor:
7.64).
12/2003;
12(22):3007-16.
DOI:10.1093/hmg/ddg316
pp.3007-16
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.
[show abstract] [hide abstract]
ABSTRACT: The frequency of E-cadherin germline mutations in countries with different incidence rates for gastric carcinoma has not been well established. The goal of this study was to assess the worldwide frequency of CDH1 germline mutations in gastric cancers coming from low- and high-risk areas. English articles using MEDLINE access (from 1998 to 2011). Search terms included CDH1, E-cadherin, germline mutation, gastric cancer, hereditary, familial and diffuse histotype.The study included all E-cadherin germline mutations identified in gastric cancer patients; somatic mutations and germline mutations reported in other tumors were excluded.The method of this study was scheduled in accordance with the "PRISMA statement for reporting systematic reviews and meta-analyses". Countries were classified as low- or middle/high risk-areas for gastric carcinoma incidence. Statistical analysis was performed to correlate the CDH1 mutation frequency with gastric cancer incidence areas. A total of 122 E-cadherin germline mutations have been identified; the majority (87.5%) occurred in gastric cancers coming from low-risk areas. In high-risk areas, we identified 16 mutations in which missense mutations were predominant. (68.8%). We verified a significant association between the mutation frequency and the gastric cancer risk area (p < 0.001: overall identified mutations in low- vs. middle/high-risk areas). E-cadherin genetic screenings performed in low-risk areas for gastric cancer identified a higher frequency of CDH1 germline mutations. This data could open new approaches in the gastric cancer prevention test; before proposing a proband candidate for the CDH1 genetic screening, geographic variability, alongside the family history should be considered.BMC Cancer 01/2012; 12:8. · 3.01 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
adhesion complex
cell behaviour
cell morphology
cell proliferation
different E-cadherin mutations
diffuse gastric cancer
E-cadherin germline mutations
epithelial-like morphology
genotype-phenotype correlation
Hereditary Diffuse Gastric Cancer syndrome
increased level
missense type harbour significant functional consequences
motile capabilities
motile phenotype
new insights
phenotype
polarised cells migrating unidirectionally
proliferation
V832M E-cadherin germline missense mutations
Wild-type E-cadherin